Skip to main content
OpenTrials

Clinical trial condition

Overweight

Explore clinical trials studying Overweight. Study availability and eligibility vary by location and protocol.

1,143 public trials 82 recruiting studies
Refine in advanced search Browse all conditions

Overweight trial results

Not Yet Recruiting

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

NCT07654361

Conditions
Body Weight, Chronic Weight Management, Nutrition Disorders, +6 more
Locations
  • ACCOMPLISH-1 Research Site Birmingham, Alabama, United States
  • ACCOMPLISH-1 Research Site Birmingham, Alabama, United States
  • ACCOMPLISH-1 Research Site Phoenix, Arizona, United States
  • ACCOMPLISH-1 Research Site Sun City West, Arizona, United States
View all 71 locations
View Trial Details
Not Yet Recruiting

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

NCT07654374

Conditions
Body Weight, Chronic Weight Management, Nutrition Disorders, +7 more
Locations
  • ACCOMPLISH-2 Research Site Birmingham, Alabama, United States
  • ACCOMPLISH-2 Research Site Chandler, Arizona, United States
  • ACCOMPLISH-2 Research Site Phoenix, Arizona, United States
  • ACCOMPLISH-2 Research Site Sun City West, Arizona, United States
View all 74 locations
View Trial Details
Not Yet Recruiting

Glycaemic Response of Arabic Bread

NCT07652320

Conditions
Body Weight, Glycaemic Response, Nutrition Disorders, +6 more
Locations
  • School of Biosciences, University of Nottingham, Sutton Bonington Campus, United Kingdom Nottingham, United Kingdom
View Trial Details
Not Yet Recruiting

A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

NCT07553299

Conditions
Body Weight, Body Weight Changes, Nutrition Disorders, +8 more
Locations
  • Clinical Study Site 202 Cullman, Alabama, United States
  • Clinical Study Site 203 Phoenix, Arizona, United States
  • Clinical Study Site 212 Tempe, Arizona, United States
  • Clinical Study Site 201 Little Rock, Arkansas, United States
View all 17 locations
View Trial Details

Related conditions